BACKGROUND AND PURPOSE: The optimal imaging method for the diagnosis of VAD remains undefined. Our aim was to evaluate the added value of HR-MR imaging for the diagnosis of VAD. MATERIALS AND METHODS: We retrospectively extracted 35 consecutive patients suspected of having acute VAD who had the following: 1) a focal lumen abnormality of the VA on CE-MRA, 2) HR-MR imaging during the initial hospital stay, and 3) clinical and imaging follow-up within 6 months. Two neurologists classified patients as either VAD (group A) or non-VAD (group B) by reviewing all the available data at hospital discharge, except HR-MR imaging data. On HR-MR imaging, 2 radiologists searched for signs of acute VAD. The 2 classifications were compared. In case of discordance, CE-MRA follow-up and axial fat-suppressed T1WI, used to obtain supportive evidence for or against VAD, were considered as the standard of reference. RESULTS: In 4/18 patients in group A, HR-MR imaging did not demonstrate any signs of acute VAD and perivertebral signal-intensity changes were attributed to venous plexus, with an unchanged lumen on follow-up. In 4/17 patients in group B, HR-MRI demonstrated a mural hematoma, with lumen normalization on follow-up CE-MRA. CONCLUSIONS: Our results encourage the use of HR-MR imaging as a second-line diagnostic tool in the event of suspicion of acute VAD and doubtful findings on standard imaging.
BACKGROUND AND PURPOSE: The optimal imaging method for the diagnosis of VAD remains undefined. Our aim was to evaluate the added value of HR-MR imaging for the diagnosis of VAD. MATERIALS AND METHODS: We retrospectively extracted 35 consecutive patients suspected of having acute VAD who had the following: 1) a focal lumen abnormality of the VA on CE-MRA, 2) HR-MR imaging during the initial hospital stay, and 3) clinical and imaging follow-up within 6 months. Two neurologists classified patients as either VAD (group A) or non-VAD (group B) by reviewing all the available data at hospital discharge, except HR-MR imaging data. On HR-MR imaging, 2 radiologists searched for signs of acute VAD. The 2 classifications were compared. In case of discordance, CE-MRA follow-up and axial fat-suppressed T1WI, used to obtain supportive evidence for or against VAD, were considered as the standard of reference. RESULTS: In 4/18 patients in group A, HR-MR imaging did not demonstrate any signs of acute VAD and perivertebral signal-intensity changes were attributed to venous plexus, with an unchanged lumen on follow-up. In 4/17 patients in group B, HR-MRI demonstrated a mural hematoma, with lumen normalization on follow-up CE-MRA. CONCLUSIONS: Our results encourage the use of HR-MR imaging as a second-line diagnostic tool in the event of suspicion of acute VAD and doubtful findings on standard imaging.
Authors: R Dittrich; R Dziewas; M A Ritter; S P Kloska; R Bachmann; I Nassenstein; G Kuhlenbaumer; W Heindel; E B Ringelstein; D G Nabavi Journal: J Neurol Date: 2005-11-24 Impact factor: 4.849
Authors: Rainald Bachmann; Isabelle Nassenstein; Hendrik Kooijman; Ralf Dittrich; Harald Kugel; Thomas Niederstadt; Gregor Kuhlenbäumer; E Bernd Ringelstein; Stefan Krämer; Walter Heindel Journal: Invest Radiol Date: 2006-02 Impact factor: 6.016
Authors: Rainald Bachmann; Isabelle Nassenstein; Hendrik Kooijman; Ralf Dittrich; Christoph Stehling; Harald Kugel; Thomas Niederstadt; Gregor Kuhlenbäumer; E Bernd Ringelstein; Stefan Krämer; Walter Heindel Journal: Invest Radiol Date: 2007-06 Impact factor: 6.016
Authors: Florian Schwarz; Frederik F Strobl; Clemens C Cyran; Andreas D Helck; Martin Hartmann; Andreas Schindler; Konstantin Nikolaou; Maximilian F Reiser; Tobias Saam Journal: Neuroradiology Date: 2016-02-23 Impact factor: 2.804
Authors: Seung Chai Jung; Ho Sung Kim; Choong-Gon Choi; Sang Joon Kim; Sun U Kwon; Dong-Wha Kang; Jong S Kim Journal: Clin Neuroradiol Date: 2016-09-27 Impact factor: 3.649
Authors: E M Coppenrath; N Lummel; J Linn; O Lenz; M Habs; K Nikolaou; M F Reiser; M Dichgans; T Pfefferkorn; T Saam Journal: Eur Radiol Date: 2013-06-04 Impact factor: 5.315
Authors: S Chai; Z Sheng; W Xie; C Wang; S Liu; R Tang; C Cao; W Xin; Z Guo; B Chang; X Yang; J Zhu; S Xia Journal: AJNR Am J Neuroradiol Date: 2020-02-27 Impact factor: 3.825